Form 4 for AMPH Amphastar Pharmaceuticals, Inc.
Accepted 2023-04-14 00:00:00 ET · period of report 2023-04-13 · accession 0001104659-23-045713 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-04-14 | 2023-04-13 | AMPH | PETERS WILLIAM J | CFO, EVP, Treas, Dir | S - Sale+OE | $42.35 | -4,868 | 105.1K | -4% | -$206.2K |
| D | 2023-04-14 | 2023-04-13 | AMPH | PETERS WILLIAM J | CFO, EVP, Treas, Dir | M - OptEx | $13.35 | +4,868 | 110.0K | +5% | +$65.0K |
| D | 2023-04-14 | 2023-04-13 | AMPH | PETERS WILLIAM J | CFO, EVP, Treas, Dir | M - OptEx | $0.00 | -4,868 | 34.6K | -12% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-04-13 | S | D | 4,868 | $42.35 | 105,148 | D | — | — | |
| 2 | Common | Common Stock | 2023-04-13 | M | A | 4,868 | $13.35 | 110,016 | D | — | — | |
| 3 | Derivative | Employee Stock Option (right to buy) | 2023-04-13 | M | D | 4,868 | $0.00 | 34,622 | D | $13.35 · — to 2027-03-16 | 4,868 Common Stock | (F2) Shares subject to the option are fully vested and immediately exercisable. |